Publication
Recombinant Human Thyrotropin Versus Thyroid Hormone Withdrawal for Radioactive Iodine Therapy in Metastatic Differentiated Thyroid Cancer: A Multicenter Retrospective Study.
Chae Moon Hong, Joonhyung Gil, Gi Jeong Cheon, Jae-Hoon Lee, Keunyoung Kim, Yeon-Hee Han, Jahae Kim, Ho-Chun Song, So Won Oh, Myoung Hyoun Kim, Jung Mi Park, Ari Chong, Hye-Kyung Shim, Yukyung Lee, Seong-Young Kwon
- Source
- PubMed
- Retrieved
- Sep 29, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260929-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
This study compared clinical and safety outcomes of radioactive iodine therapies administered after thyroid hormone withdrawal (THW) versus recombinant human thyrotropin (rhTSH) in patients with differentiated thyroid cancer and distant metastases, using both patient- and therapy-based analyses.…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Thyroid Gland Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available